• Explore /
  • Poster
  • / Second-line VEGF TKI after IO combination therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).

Second-line VEGF TKI after IO combination therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).

Abstract Poster

Authors

null

Igor Stukalin

Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada

Igor Stukalin , Shaan Dudani , Connor Wells , Chun Loo Gan , Sumanta K. Pal , Nazli Dizman , Thomas Powles , Frede Donskov , Lori Wood , Ziad Bakouny , Christian K. Kollmannsberger , Naveen S. Basappa , Aaron Richard Hansen , Guillermo de Velasco , Benoit Beuselinck , Christina M. Canil , Ulka N. Vaishampayan , Neeraj Agarwal , Toni K. Choueiri , Daniel Yick Chin Heng

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 684)

Abstract #

684

Poster Bd #

G4

Abstract Disclosures

Similar Posters

First Author: John McGrane

First Author: Tian Zhang

First Author: Tian Zhang

First Author: Shaan Dudani